Literature DB >> 31451012

Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies.

Junhao Liu1, Jo A Wick1, Dinesh Pal Mudaranthakam1, Yu Jiang2, Matthew S Mayo1, Byron J Gajewski1,3.   

Abstract

BACKGROUND: Monitoring subject recruitment is key to the success of a clinical trial. Accordingly, researchers have developed accrual-monitoring tools to support the design and conduct of trials. At an institutional level, delays in identifying studies with high risk of accrual failure can lead to inefficient and costly trials with little chances of meeting study objectives. Comprehensive accrual monitoring is necessary to the success of the research enterprise.
METHODS: This article describes the design and implementation of the University of Kansas Cancer Center Accrual Prediction Program, a web-based platform was developed to support comprehensive accrual monitoring and prediction for all active clinical trials. The Accrual Prediction Program provides information on accrual, including the predicted completion date, predicted number of accrued subjects during the pre-specified accrual period, and the probability of achieving accrual targets. It relies on a Bayesian accrual prediction model to combine protocol information with real-time trial enrollment data and disseminates results via web application.
RESULTS: First released in 2016, the Accrual Prediction Program summarizes enrollment information for active studies categorized by various trial attributes. The web application supports real-time evidence-based decision making for strategic resource allocation and study management of over 120 ongoing clinical trials at the University of Kansas Cancer Center.
CONCLUSION: The Accrual Prediction Program makes accessing comprehensive accrual information manageable at an institutional level. Cancer centers or even entire institutions can reproduce the Accrual Prediction Program to achieve real-time comprehensive monitoring and prediction of subject accrual to aid investigators and administrators in the design, conduct, and management of clinical trials.

Entities:  

Keywords:  Cancer center; patient recruitment; subject accrual; web-based tool

Year:  2019        PMID: 31451012      PMCID: PMC6904514          DOI: 10.1177/1740774519871474

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  10 in total

1.  The importance of doing trials right while doing the right trials.

Authors:  David M Dilts; Steven K Cheng
Journal:  Clin Cancer Res       Date:  2011-11-09       Impact factor: 12.531

2.  A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program.

Authors:  John F Scoggins; Scott D Ramsey
Journal:  J Natl Cancer Inst       Date:  2010-08-03       Impact factor: 13.506

3.  Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials.

Authors:  Caroline S Bennette; Scott D Ramsey; Cara L McDermott; Josh J Carlson; Anirban Basu; David L Veenstra
Journal:  J Natl Cancer Inst       Date:  2015-12-29       Impact factor: 13.506

4.  Predicting accrual in clinical trials with Bayesian posterior predictive distributions.

Authors:  Byron J Gajewski; Stephen D Simon; Susan E Carlson
Journal:  Stat Med       Date:  2008-06-15       Impact factor: 2.373

5.  Clinical trials in crisis: Four simple methodologic fixes.

Authors:  Andrew J Vickers
Journal:  Clin Trials       Date:  2014-10-01       Impact factor: 2.486

6.  Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors.

Authors:  Yu Jiang; Steve Simon; Matthew S Mayo; Byron J Gajewski
Journal:  Stat Med       Date:  2014-11-06       Impact factor: 2.373

Review 7.  Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors.

Authors:  Edward J Mills; Dugald Seely; Beth Rachlis; Lauren Griffith; Ping Wu; Kumanan Wilson; Peter Ellis; James R Wright
Journal:  Lancet Oncol       Date:  2006-02       Impact factor: 41.316

8.  On the Existence of Constant Accrual Rates in Clinical Trials and Direction for Future Research.

Authors:  Byron J Gajewski; Stephen D Simon; Susan E Carlson
Journal:  Int J Stat Probab       Date:  2012-11-01

9.  Some issues in predicting patient recruitment in multi-centre clinical trials.

Authors:  Andisheh Bakhshi; Stephen Senn; Alan Phillips
Journal:  Stat Med       Date:  2013-09-17       Impact factor: 2.373

10.  Bayesian accrual prediction for interim review of clinical studies: open source R package and smartphone application.

Authors:  Yu Jiang; Peter Guarino; Shuangge Ma; Steve Simon; Matthew S Mayo; Rama Raghavan; Byron J Gajewski
Journal:  Trials       Date:  2016-07-22       Impact factor: 2.279

  10 in total
  3 in total

1.  Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times.

Authors:  Junhao Liu; Jo Wick; Yu Jiang; Matthew Mayo; Byron Gajewski
Journal:  Pharm Stat       Date:  2020-04-21       Impact factor: 1.894

2.  Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative study.

Authors:  Benjamin Kasenda; Junhao Liu; Yu Jiang; Byron Gajewski; Cen Wu; Erik von Elm; Stefan Schandelmaier; Giusi Moffa; Sven Trelle; Andreas Michael Schmitt; Amanda K Herbrand; Viktoria Gloy; Benjamin Speich; Sally Hopewell; Lars G Hemkens; Constantin Sluka; Kris McGill; Maureen Meade; Deborah Cook; Francois Lamontagne; Jean-Marc Tréluyer; Anna-Bettina Haidich; John P A Ioannidis; Shaun Treweek; Matthias Briel
Journal:  Trials       Date:  2020-08-21       Impact factor: 2.279

3.  Improving the efficiency of clinical trials by standardizing processes for Investigator Initiated Trials.

Authors:  Dinesh Pal Mudaranthakam; Milind A Phadnis; Ron Krebill; Lauren Clark; Jo A Wick; Jeffrey Thompson; John Keighley; Byron J Gajewski; Devin C Koestler; Matthew S Mayo
Journal:  Contemp Clin Trials Commun       Date:  2020-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.